Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block in Cerebral Small Vessel Disease
NCT06226415Completed
- Start
- Jan 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in Cerebral Small Vessel Disease (CSVD) (2 arms). Primary endpoint: Penetration-Aspiration Scale at day 14. Started Jan 2024; status: completed.
02
Drugs
lidocaine
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT06226415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06226415.